Early SARS-CoV-2-associated acute transverse myelitis: A case for neurotropism?


Journal

Journal of internal medicine
ISSN: 1365-2796
Titre abrégé: J Intern Med
Pays: England
ID NLM: 8904841

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 6 7 2022
medline: 21 9 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

There are increasing reports of immune-mediated and para-infectious syndromes beyond the well-known respiratory manifestations of severe-acute-respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the spectrum of severe neurological sequelae of SARS-CoV-2 remains undefined. We present the case of a 66-year-old female with rapidly progressive lower limb neurology 3 days post SARS-CoV-2 infection. Clinical and radiological findings were in keeping with transverse myelitis and treatment success was achieved with methylprednisolone and remdesivir. This report will discuss the associations between SARS-CoV-2 and acute transverse myelitis. We believe this is one of few described cases of early SARS-CoV-2-associated transverse myelitis secondary to neurotropism and the first successfully treated with the inclusion of remdesivir in the therapeutic regimen.

Identifiants

pubmed: 35781711
doi: 10.1111/joim.13542
pmc: PMC9350090
doi:

Substances chimiques

Methylprednisolone X4W7ZR7023

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

679-683

Informations de copyright

© 2022 The Association for the Publication of the Journal of Internal Medicine.

Références

Immun Inflamm Dis. 2021 Mar;9(1):48-58
pubmed: 33332737
J Intern Med. 2022 Oct;292(4):679-683
pubmed: 35781711
Adv Exp Med Biol. 2014;807:75-96
pubmed: 24619619
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
J Neurol Sci. 2021 Feb 15;421:117316
pubmed: 33561753
Front Immunol. 2021 Apr 26;12:653786
pubmed: 33981305
Semin Neurol. 2012 Apr;32(2):97-113
pubmed: 22961185
J Neurol. 2021 Sep;268(9):3059-3071
pubmed: 33486564
J Neurol. 2020 Jul;267(7):1880-1882
pubmed: 32361836
J Med Virol. 2020 Jun;92(6):552-555
pubmed: 32104915
N Engl J Med. 2022 Jan 27;386(4):305-315
pubmed: 34937145
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998
pubmed: 32167747
Acta Neurol Scand. 2022 Jan;145(1):5-9
pubmed: 34750810
Radiol Case Rep. 2020 Jun 06;15(9):1591-1595
pubmed: 32685076

Auteurs

Irene F Lu (IF)

Barwon Health, University Hospital Geelong, Geelong, Australia.

Jack S Cornish (JS)

Barwon Health, University Hospital Geelong, Geelong, Australia.

Aadith Ashok (A)

Barwon Health, University Hospital Geelong, Geelong, Australia.

Siew Kar Chen (SK)

Barwon Health, University Hospital Geelong, Geelong, Australia.

Eugene Athan (E)

Barwon Health, University Hospital Geelong, Geelong, Australia.
School of Medicine, Deakin University, Geelong, Australia.

Andrew Hughes (A)

Barwon Health, University Hospital Geelong, Geelong, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH